| [68Ga]Ga-HBED-CC-exendin-4 and [68Ga]Ga-NOTA-exendin-4 PET/CT Imaging in the Same Group of Insulinoma Patients (NCT05034783) | Peking Union Medical College Hospital | 2021-10-01 |
| The Clinical Application of 68Ga-NOTA-exendin-4 PET/CT in Detecting Insulinoma (NCT04979611) | First Affiliated Hospital of Fujian Medical University | 2020-08-01 |
| CGM (Continuous Glucose Monitoring) Use in Diagnosis of Spontaneous and Reactive Hypoglycaemia (NCT04452396) | Barts & The London NHS Trust | 2019-12-01 |
| Clinical Evaluation of 68Ga-NOTA-MAL-Cys39-exendin-4 Positron Emission Tomography in the Detection of Insulinoma (NCT04185350) | Nanjing First Hospital, Nanjing Medical University | 2019-05-05 |
| Application of Raw Corn Starch on Patients With Insulinoma (NCT03930368) | Peking Union Medical College Hospital | 2019-04-15 |
| Glucagon-like Peptide-1 Receptor PET/CT in GLP-1R Related Disease (NCT06725693) | Tianjin Medical University | 2019-02-01 |
| DOTATOC PET/CT for Imaging NET Patients (NCT03583528) | British Columbia Cancer Agency | 2018-07-11 |
| Pasireotide in Hyperinsulinemic Hypoglycemia (NCT03053284) | Montefiore Medical Center | 2017-04-01 |
| Regorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine Tumors (NCT02259725) | University of Southern California | 2016-08-16 |
| 68Ga-NODAGA-exendin-4 PET/CT for Diagnostic Imaging in AHH (NCT03189953) | Radboud University Medical Center | 2015-04-01 |
| Pharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kidney Cancer (NCT02273752) | Emory University | 2014-11-01 |
| Dovitinib Lactate in Treating Patients With Pancreatic Neuroendocrine Tumors (NCT02108782) | Academic and Community Cancer Research United | 2014-10-01 |
| Everolimus in Patients With Pancreatic Neuroendocrine Tumors Metastatic to the Liver Previously Treated With Surgery (NCT02031536) | ECOG-ACRIN Cancer Research Group | 2014-04-10 |
| EUS-guided Ethanol Ablation of an Insulinoma (NCT02121366) | Guangxi Medical University | 2014-03-01 |
| 68Ga-NOTA-exendin-4 PET/CT for the Localization of Insulinoma and Diagnosis of Nesidioblastosis (NCT02560376) | Peking Union Medical College Hospital | 2014-02-01 |
| Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors (NCT01824875) | ECOG-ACRIN Cancer Research Group | 2013-08-08 |
| Capecitabine, Temozolomide, and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors (NCT01525082) | Shaheen Shagufta | 2012-12-01 |
| Whole Body 111In-exendin-4 Imaging Study in Insulinoma Patients (NCT00937079) | University Hospital, Basel, Switzerland | 2007-11-01 |
| Sorafenib Tosylate in Treating Patients With Progressive Metastatic Neuroendocrine Tumors (NCT00131911) | National Cancer Institute (NCI) | 2005-06-01 |
| Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors (NCT00655655) | Mayo Clinic | 2004-12-01 |
| Romidepsin in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors (NCT00084461) | National Cancer Institute (NCI) | 2004-03-01 |
| Gefitinib in Treating Patients With Progressive Metastatic Neuroendocrine Tumors (NCT00075439) | National Cancer Institute (NCI) | 2003-12-01 |
| Laparoscopy to Remove Pancreatic Tumors (Insulinomas) (NCT00005910) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2000-06-01 |
| Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu (NCT00004074) | National Cancer Institute (NCI) | 1999-08-01 |
| Diagnosing and Treating Low Blood Sugar Levels (NCT00001276) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 1991-05-21 |